Literature DB >> 4053473

Sequelae of sural nerve biopsies.

R Poburski, J P Malin, E Stark.   

Abstract

Sequelae of sural nerve biopsy were examined in 24 patients. Fourteen subjects reported persisting pain or dysaesthesias for more than one year. In nine patients the symptoms were mild, in five severe. Hypaesthesia of the lateral aspect of the foot was found in 17 out of 18 patients with otherwise normal or only slightly impaired sensory function. In one patient sural nerve biopsy did not cause permanent sensory loss. Pain and dysaesthesia were not significantly related to post-biopsy or generalized hypaesthesia.

Entities:  

Mesh:

Year:  1985        PMID: 4053473     DOI: 10.1016/0303-8467(85)90006-x

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Complications following sural and peroneal nerve biopsies.

Authors:  David A Hilton; John Jacob; Liz Househam; Connie Tengah
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-05       Impact factor: 10.154

2.  Prospective study of the usefulness of sural nerve biopsy.

Authors:  C M Gabriel; R Howard; N Kinsella; S Lucas; I McColl; G Saldanha; S M Hall; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

3.  Clinical and biometrical 12-month follow-up in patients after reconstruction of the sural nerve biopsy defect by the collagen-based nerve guide Neuromaix.

Authors:  Ahmet Bozkurt; Kristl G Claeys; Simone Schrading; Jana V Rödler; Haktan Altinova; Jörg B Schulz; Joachim Weis; Norbert Pallua; Sabien G A van Neerven
Journal:  Eur J Med Res       Date:  2017-09-22       Impact factor: 2.175

4.  The proximal medial sural nerve biopsy model: a standardised and reproducible baseline clinical model for the translational evaluation of bioengineered nerve guides.

Authors:  Ahmet Bozkurt; Sabien G A van Neerven; Kristl G Claeys; Dan Mon O'Dey; Angela Sudhoff; Gary A Brook; Bernd Sellhaus; Jörg B Schulz; Joachim Weis; Norbert Pallua
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.